Risk of chronic liver disease in HBsAG and/or anti-HCV-positive renal allograft recipients.
Durlik
M
M
Transplantation Institute, Warsaw Medical School, Poland.
Gaciong
Z
Z
Soluch
L
L
Walecka-Zielecka
B
B
Rancewicz
Z
Z
Rowińska
D
D
Rowiński
W
W
Szmidt
J
J
Lao
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D018937:Hepatitis C Antibodies / Q000097:blood*; D006525:Hepatitis, Viral, Human / Q000453:epidemiology* / Q000401:mortality; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D012189:Retrospective Studies; D013997:Time Factors
D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies